Dr Prashant Saxena, Associate Director and Head, Pulmonology and Sleep Medicine; Associate Director, Critical Care, Max Smart Super Speciality Hospital answers all the common questions regarding Post...
The British regulator's approval follows that of the European Medicines Agency and US Food and Drug Administration last month for the younger cohort to receive the...
The Drug Controller General of India said it has waived the requirement for foreign companies to carry out post-launch bridging trials and to test the quality...
World Health Organisation has already listed the following COVID-19 vaccines: Pfizer/BioNTech, Astrazeneca-SK Bioscience, Serum Institute of India, Astra Zeneca EU, Janssen, Moderna and Sinopharm vaccines for...
The total number of COVID vaccinations done in India is nearly equivalent to the total number done in the United States and our population is four...
There is international research underway on the mixing of COVID-19 vaccines as the possibility of a positive effect is also plausible but a harmful reaction cannot...
India and Russia are planning to manufacture around 35-40 million COVID-19 vaccine doses every month that will start from August or September
Dr Reddy's Laboratories Limited had applied for the grant of permission to import and market Gam-COVID-Vac combined vector vaccine, popularly called Sputnik-V, developed by Gamaleya Institute,...
Amid concerns that reports of rare side-effects could undermine vaccine confidence, experts have emphasised that clotting risks for both shots remain extremely low and the vaccines...
If an individual gets COVID-19 between the two doses of the vaccine, the second dose should be taken after six to eight weeks, said Dr Naresh...
According to a press release, people seeking inoculation at these centres will need to register on CoWIN and book the desired time by dialing 8800015999 (drive-through)...
Immunity takes some time after the vaccination, therefore, it is essential to be extra careful at least two weeks after the second dose of vaccination and...
